促红细胞生成素后多钻孔经硬膜血管重建治疗脑灌注不足卒中患者:一项随机对照试验
本前瞻性随机盲法终点试验纳入急性缺血性卒中伴灌注损伤分级≥2级且症状发作14天内、影像学示狭窄闭塞机制、经股脑动脉造影无经硬膜侧支的患者,随机接受多钻孔+促红细胞生成素或多钻孔 alone。结果显示联合组经半球和经钻孔血管重建率显著更高,灌注参数显著改善,治疗相关并发症无差异,促红细胞生成素为成功半球血管重建的独立因素(OR 6.41,95%CI 1.08-38.02)。
要点
- 多钻孔联合促红细胞生成素组经半球血管重建19/21(90.5%)vs 多钻孔 alone组12/21(57.1%)。
- 联合组经钻孔血管重建42/58(72.4%)vs 多钻孔 alone组30/58(51.7%)。
- 促红细胞生成素为成功半球血管重建的独立因素(OR 6.41,95%CI 1.08-38.02)。
核心结论
- 多钻孔联合促红细胞生成素对于伴灌注损伤的急性狭窄闭塞性卒中患者强化经硬膜血管重建是安全可行的。
研究设计与样本
- 前瞻性、随机、盲法终点试验,纳入急性缺血性卒中伴灌注损伤分级≥2级、症状发作14天内、影像学示狭窄闭塞机制、经股脑动脉造影无经硬膜侧支的患者,随机分为多钻孔+促红细胞生成素组或多钻孔 alone组。
- 目标44例,评估42例,2例失访,联合组和多钻孔 alone组各21例。
主要发现
- 联合组经半球血管重建19/21(90.5%)vs 多钻孔 alone组12/21(57.1%),联合组显著更高。
- 联合组经钻孔血管重建42/58(72.4%)vs 多钻孔 alone组30/58(51.7%),联合组显著更高。
- 联合组相对多钻孔 alone组灌注参数显著改善。
- 两组治疗相关并发症无差异。
- 调整潜在协变量后,促红细胞生成素使用为成功半球血管重建的独立因素(OR 6.41,95%CI 1.08-38.02)。
关键数值与推荐
- 主要结局为6个月时血管重建成功(经半球和经钻孔),次要结局为不良事件。
- 灌注损伤分级≥2级、症状发作14天内、经股脑动脉造影无经硬膜侧支为纳入条件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with acute symptomatic stroke, reinforcement of transdural angiogenesis using multiple burr hole (MBH) procedures after EPO (erythropoietin) treatment has rarely been addressed. We aimed to investigate the efficacy and safety of cranial MBH procedures under local anesthesia for augmenting transdural revascularization after EPO treatment in patients with stroke with perfusion impairments. METHODS: This prospective, randomized, blinded-end point trial recruited patients with acute ischemic stroke with a perfusion impairment of grade ≥2 within 14 days of symptom onset, steno-occlusive mechanisms on imaging examinations, and absence of transdural collaterals on transfemoral cerebral angiography. Patients were randomly assigned to receive MBH + EPO or MBH alone. The primary and secondary outcomes were revascularization success (trans-hemispheric and trans-burr hole) at 6 months and adverse events, respectively. RESULTS: We evaluated 42 of the 44 targeted patients, with 2 patients lost to follow-up. The combined and MBH-only (n=21 each) groups showed no differences in demographic characteristics and baseline perfusion parameters. Significantly, more cases of trans-hemispheric (19/21 [90.5%] versus 12/21 [57.1%]) and trans-burr hole (42/58 [72.4%] versus 30/58 [51.7%]) revascularization and significant improvements in perfusion parameters were observed in the combined group relative to the MBH-only group. No differences in treatment-related complications were observed between groups. Even after adjustment for potential covariates, EPO usage was an independent factor of successful hemispheric revascularization in this study (odds ratio, 6.41 [95% CI, 1.08-38.02]). CONCLUSIONS: The combination of MBH and EPO is safe and feasible for reinforcing transdural revascularization in acute steno-occlusive patients with perfusion impairments. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT02603406.
引用
- Hong JM, Choi MH, Park GH, et al. Transdural Revascularization by Multiple Burrhole After Erythropoietin in Stroke Patients With Cerebral Hypoperfusion: A Randomized Controlled Trial. Stroke. 2022. PMID: 35579016. doi:10.1161/STROKEAHA.122.038650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。